- Home
- FOR vs CLDX Comparison
FOR vs CLDX Comparison
Compare FOR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- CLDX
- Stock Information
- Founded
- FOR 2005
- CLDX N/A
- Country
- FOR United States
- CLDX United States
- Employees
- FOR N/A
- CLDX N/A
- Industry
- FOR Real Estate
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FOR Finance
- CLDX Health Care
- Exchange
- FOR Nasdaq
- CLDX Nasdaq
- Market Cap
- FOR N/A
- CLDX 1.3B
- IPO Year
- FOR 2007
- CLDX 2008
- Fundamental
- Price
- FOR $21.14
- CLDX $18.15
- Analyst Decision
- FOR Strong Buy
- CLDX Buy
- Analyst Count
- FOR 3
- CLDX 8
- Target Price
- FOR $34.00
- CLDX $54.29
- AVG Volume (30 Days)
- FOR 215.4K
- CLDX 749.8K
- Earning Date
- FOR 04-17-2025
- CLDX 05-05-2025
- Dividend Yield
- FOR N/A
- CLDX N/A
- EPS Growth
- FOR N/A
- CLDX N/A
- EPS
- FOR 3.56
- CLDX N/A
- Revenue
- FOR $1,453,900,000.00
- CLDX $7,020,000.00
- Revenue This Year
- FOR $10.37
- CLDX N/A
- Revenue Next Year
- FOR $11.16
- CLDX $27.01
- P/E Ratio
- FOR $5.93
- CLDX N/A
- Revenue Growth
- FOR N/A
- CLDX 1.99
- 52 Week Low
- FOR $20.70
- CLDX $17.63
- 52 Week High
- FOR $40.86
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- FOR 39.68
- CLDX 34.76
- Support Level
- FOR $21.70
- CLDX $19.48
- Resistance Level
- FOR $22.28
- CLDX $20.38
- Average True Range (ATR)
- FOR 0.60
- CLDX 1.04
- MACD
- FOR 0.01
- CLDX -0.02
- Stochastic Oscillator
- FOR 19.73
- CLDX 12.32
Stock Price Comparison Chart: FOR vs CLDX
■ FOR
■ CLDX
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.